FierceHealthcareFierceHealthITFierceHealthFinanceFierceEMRHospital ImpactFierceMobileHealthcare   FiercePharma

SPOTLIGHT: Lilly to pay $500M to settle Zyprexa claims

January 4, 2007 — 8:01pm ET
Tools
Tags
Diabetes
settle
Eli Lilly


Eli Lilly has agreed to pay as much as $500 million to settle 18,000 claims that people who took the drug developed diabetes. Previous data indicated that patients on Zyprexa were 3.5 times more likely to experience elevated blood sugar levels than volunteers taking a placebo, and the disease is heavily influenced by weight gain and blood sugar levels. Report

Bookmark and Share
Get Your FREE FierceHealthcare Email Newsletter:
Be the first to comment

Comments

By Anonymous | Posted 4:06pm | January 5, 2007

Many of the longtime zyprexa users like myself who developed diabetes were given it 'off label' because it was being pushed on my doctor by Lilly drug reps.

The now notorious Zyprexa diabetes connection is elaborated at thousands of pages on line.
My own local clinic and clinics everywhere have stopped dispensing Zyprexa except as a PRN for acute cases.

Eli Lilly's zyprexa gravy train will stall soon enough.
I am Daniel Haszard 4 year zyprexa user who got diabetes from it.

Lilly made a mistake motivated by a desire for profits (greed) now it's time to face the music.Lilly occasionally comes out with theses periodic media PR's on compensation then nothing happens and you wonder why victims get indignant.
--
Daniel Haszard www.zyprexa-victims.com

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.